Pharmaceutical News

RSS

New “Consensus Document” can help manage wound care

DURING the COVID-19 pandemic, pharmacists have increasingly played a key role as being the first point of contact for people with wounds, both chronic and acute.

19 May 2021

New mathematical model predicts how bacterial mutations influence the success of antibiotic treatments

Scientists have developed a mathematical model that predicts how the number and effects of bacterial mutations leading to drug resistance will influence the success of antibiotic treatments.

19 May 2021

Combination approach can improve the success rate of cancer treatment

A new cancer vaccine could boost the positive effects of existing immunotherapy drugs, improving the success rate of treatments from 20% to 75% of cases, according to a new study by immunologists from the University of Konstanz.

19 May 2021

Medications commonly prescribed for schizophrenia linked to cognitive impairment

Writing in the May 14, 2021 issue of The American Journal of Psychiatry, a multi-institution team of scientists led by researchers at University of California San Diego School of Medicine report that medications commonly prescribed to reduce the severity of physical and mental health symptoms associated with schizophrenia may have a cumulative effect of worsening cognitive function in patients.

18 May 2021

High levels of trust in science can make people more confident about COVID-19 vaccines

People are more likely to get vaccinated against diseases such as COVID-19 in countries where societal trust in science is high.

18 May 2021

New method provides greater quality control and safety of heparin drug

A new method to analyze the blood thinning drug Heparin has been developed that can pinpoint contaminants more accurately and quickly, providing greater quality control and safety.

17 May 2021

Sacubitril/valsartan drug did not significantly reduce cardiovascular death after heart attack

The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin-converting enzyme (ACE) inhibitor proven effective in improving survival following heart attacks.

17 May 2021

Phase 2 trial shows INO-4800 SARS-CoV-2 DNA vaccine safe and tolerable in adults

Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.

16 May 2021

Oral TXA is equally efficacious at preventing blood loss in orthopedic surgery, interim study suggests

Interim results of a study conducted by researchers at Hospital for Special Surgery (HSS) suggest that oral tranexamic acid (TXA) is non-inferior to intravenous (IV) TXA in preventing blood loss in total knee and total hip replacement surgery.

14 May 2021

Study: Duloxetine may reduce cumulative opioid use after total knee arthroplasty

In a study conducted by researchers at Hospital for Special Surgery (HSS), cumulative opioid use was reduced by 30% in a patient group that received duloxetine after total knee arthroplasty (TKA) compared with patients who received placebo.

13 May 2021

Scientists unveil new Ebola virus vaccine design

Scientists at Scripps Research have unveiled a new Ebola virus vaccine design, which they say has several advantages over standard vaccine approaches for Ebola and related viruses that continue to threaten global health.

13 May 2021

mRNA-based COVID-19 vaccines are effective against Indian SARS-CoV-2 variant, says study

A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

12 May 2021

Don’t eat the yellowstone snow: Elite ski resort aims to turn sewage into powder

An exclusive Montana resort wants to turn sewage into snow so that its rich and famous members can ski its slopes in a winter season that's shrinking because of climate change.

12 May 2021

Study: Pink drinks can help people run faster and further compared to clear drinks

A new study led by the Centre for Nutraceuticals in the University of Westminster shows that pink drinks can help to make you run faster and further compared to clear drinks.

12 May 2021

Inappropriate antibiotic prescribing for upper respiratory tract infections contributes to antibiotic resistance

Inappropriate antibiotic prescribing for upper respiratory tract infections contributes to antibiotic resistance, making some bacterial infections difficult to treat.

12 May 2021

Study confirms rare blood clotting risk linked to ChAdOx1-S vaccine - benefits still outweigh risks

New research published in BMJ confirmed evidence of blood clotting finding a small risk after receiving one Oxford-AstraZeneca ChAdOx1-S severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine.

12 May 2021

New study shows that COVID-19 vaccines are safe in pregnancy

A new Northwestern Medicine study of placentas from patients who received the COVID-19 vaccine during pregnancy found no evidence of injury, adding to the growing literature that COVID-19 vaccines are safe in pregnancy.

12 May 2021

New class of anti-cancer compounds effectively kills liver and breast cancer cells

A team of Oregon State University scientists has discovered a new class of anti-cancer compounds that effectively kill liver and breast cancer cells.

12 May 2021

Researchers discover the second possible effective mechanism of remdesivir

The virostatic agent remdesivir was developed to disrupt an important step in the propagation of RNA viruses, to which SARS-CoV-2 also belongs: the reproduction of the virus's own genetic material. This is present as RNA matrices with which the host cell directly produces virus proteins.

11 May 2021

FDA expands emergency use authorization for Pfizer-BioNTech COVID-19 Vaccine

Today, the U.S. Food and Drug Administration expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to include adolescents 12 through 15 years of age.

10 May 2021

Pharmaceutical News

New “Consensus Document” can help manage wound care

New mathematical model predicts how bacterial mutations influence the success of antibiotic treatments

Combination approach can improve the success rate of cancer treatment

Medications commonly prescribed for schizophrenia linked to cognitive impairment

High levels of trust in science can make people more confident about COVID-19 vaccines

New method provides greater quality control and safety of heparin drug

Sacubitril/valsartan drug did not significantly reduce cardiovascular death after heart attack

Phase 2 trial shows INO-4800 SARS-CoV-2 DNA vaccine safe and tolerable in adults

Oral TXA is equally efficacious at preventing blood loss in orthopedic surgery, interim study suggests

Study: Duloxetine may reduce cumulative opioid use after total knee arthroplasty

Scientists unveil new Ebola virus vaccine design

mRNA-based COVID-19 vaccines are effective against Indian SARS-CoV-2 variant, says study

Don’t eat the yellowstone snow: Elite ski resort aims to turn sewage into powder

Study: Pink drinks can help people run faster and further compared to clear drinks

Inappropriate antibiotic prescribing for upper respiratory tract infections contributes to antibiotic resistance

Study confirms rare blood clotting risk linked to ChAdOx1-S vaccine - benefits still outweigh risks

New study shows that COVID-19 vaccines are safe in pregnancy

New class of anti-cancer compounds effectively kills liver and breast cancer cells

Researchers discover the second possible effective mechanism of remdesivir

FDA expands emergency use authorization for Pfizer-BioNTech COVID-19 Vaccine

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News